Company Overview

Sandoz is a Novartis company with a reputation for quality going back to its roots in the 19th century (foundation of Sandoz by Edouard Sandoz in 1886).

The Sandoz Vision is to be the main provider of high quality, affordable medicines helping secure long-term access to healthcare for people around the world.

Sandoz, a global generics leader, develops, produces and markets medicines that are no longer protected by patents, along with pharmaceutical and biotechnological active substances.

Sandoz offers patients more than 130 molecules in over 350 forms in the UK;  worldwide Sandoz offers patients more than 950 molecules in over 5000 forms.

Sandoz medicines are available to about 90% of the world’s population.

Sandoz produces far more than just traditional off-patent products. We differentiate ourselves from other companies by developing and producing difficult-to-make generics that require an exceptionally high degree of expertise and knowledge and often involve complex high-tech delivery systems. These range from oral solids through injectables and patch technologies to state-of-the-art biosimilars  – approved versions of biopharmaceutical medicines.

Sandoz has eight major global development centers and a worldwide network of production sites and technology centers of excellence. 

Sandoz reported generic pharmaceutical sales of USD 7.2 billion in 2007 and employs more than 23,000 associates in 130 countries.

Sandoz global headquarters are based in Holzkirchen, Germany, just south of Munich.